Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximab

S. HongengP. TardtongS. WorapongpaiboonA. UngkanontS. JootarMahidol University2018-07-242018-07-242002-01-01Bone Marrow Transplantation. Vol.29, No.10 (2002), 871-872026833692-s2.0-0035998368https://repository.li.mahidol.ac.th/handle/123456789/20569Here, we report a case of paediatric β-thalassaemia major patient who underwent unrelated T cell-nondepleted bone marrow transplantation and developed a complication of autoimmune haemolytic anaemia (AIHA) refractory to corticosteroid and intravenous immunoglobulin therapy. After this child received two doses (375 mg/m2/dose) of rituximab (anti-CD20 monoclonal antibody), his AIHA was resolved.Mahidol UniversityMedicineSuccessful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximabArticleSCOPUS10.1038/sj.bmt.1703551